STERIS Aktie

242,40USD -2,73USD -1,11%
STERIS für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PGLV / ISIN: IE00BFY8C754

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 12 770 16 422 17 000 18 179 17 787
Umsatz pro Mitarbeiter in Mio. EUR 0,24 0,28 0,29 0,28 0,31

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 1 212 1 879 2 011 2 869 2 001
Summe Anlagevermögen 5 363 9 545 8 810 8 195 8 146
Summe Aktiva 6 574 11 424 10 822 11 064 10 147

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 2 683 4 879 4 735 4 748 3 531
Summe Eigenkapital 3 891 6 545 6 087 6 315 6 616
Summe Passiva 6 574 11 424 10 822 11 064 10 147

Adresse

70 Sir John Rogerson's Quay, 2 Dublin
Internet http://www.steris.com

Management

Bill Brodbeck
Vice President-Regulatory Affairs
Cary L. Majors
Senior Vice President & President-Healthcare
Christopher S. Holland
Independent Director
Cynthia L. Feldmann
Independent Director
Daniel A. Carestio
President, Chief Executive Officer & Director
Esther M. Alegria
Independent Director
Jacqueline B. Kosecoff
Independent Director
John Adam Zangerle
Secretary, Senior Vice President & General Counsel
Julie Winter
VP-Investor Relations & Corporate Communications
Karen Louise Burton
Chief Accounting Officer & Vice President
Laura Weien
Vice President & Chief Compliance Officer
Mary Clare Fraser
Chief Human Resources Officer & Senior VP
Michael Joseph Tokich
Chief Financial Officer & Senior Vice President
Mohsen M. Sohi
Chairman
Nirav R. Shah
Independent Director
Paul E. Martin
Independent Director
Renato G. Tamaro
Treasurer & Vice President
Richard Carroll Breeden
Independent Director
Richard Martin Steeves
Independent Director
Walter M. Rosebrough
Chief Executive Officer-Emeritus